This is a Validated Antibody Database (VAD) review about human phospholipase C beta 4, based on 1 published articles (read how Labome selects the articles), using phospholipase C beta 4 antibody in all methods. It is aimed to help Labome visitors find the most suited phospholipase C beta 4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
phospholipase C beta 4 synonym: ARCND2; PI-PLC; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4; 1-phosphatidyl-D-myo-inositol-4,5-bisphosphate; PLC-beta-4; dJ1119D9.2 (Phopholipase C, beta 4 (1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Beta 4)); inositoltrisphosphohydrolase; monophosphatidylinositol phosphodiesterase; phosphoinositidase C; phosphoinositide phospholipase C-beta-4; triphosphoinositide phosphodiesterase

Santa Cruz Biotechnology
mouse monoclonal (A-8)
  • immunohistochemistry; human; 1:50; loading ...; fig 8a
Santa Cruz Biotechnology phospholipase C beta 4 antibody (Santa Cruz, sc- 166131) was used in immunohistochemistry on human samples at 1:50 (fig 8a). Oncotarget (2016) ncbi
Articles Reviewed
  1. Frantzi M, Klimou Z, Makridakis M, Zoidakis J, Latosinska A, Borràs D, et al. Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models. Oncotarget. 2016;7:70750-70768 pubmed publisher